These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27519549)

  • 1. Hepatic Clearance Predictions from In Vitro-In Vivo Extrapolation and the Biopharmaceutics Drug Disposition Classification System.
    Bowman CM; Benet LZ
    Drug Metab Dispos; 2016 Nov; 44(11):1731-1735. PubMed ID: 27519549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?
    Kameyama T; Sodhi JK; Benet LZ
    Drug Metab Dispos; 2022 Apr; 50(4):401-412. PubMed ID: 35086847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.
    Camenisch G; Umehara K
    Biopharm Drug Dispos; 2012 May; 33(4):179-94. PubMed ID: 22407504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.
    Benet LZ
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):162-7. PubMed ID: 20002064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
    Hosey CM; Chan R; Benet LZ
    AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
    Wu CY; Benet LZ
    Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction.
    Bowman CM; Benet LZ
    J Pharm Sci; 2019 Jul; 108(7):2500-2504. PubMed ID: 30817922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
    Manevski N; Umehara K; Parrott N
    Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System.
    Liu W; Yan T; Chen K; Yang L; Benet LZ; Zhai S
    Pharmacotherapy; 2020 Apr; 40(4):274-290. PubMed ID: 32100890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
    Bocci G; Oprea TI; Benet LZ
    AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.
    Golfar Y; Shayanfar A
    J Pharm Pharm Sci; 2019; 22(1):247-269. PubMed ID: 31287788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDDCS class prediction for new molecular entities.
    Broccatelli F; Cruciani G; Benet LZ; Oprea TI
    Mol Pharm; 2012 Mar; 9(3):570-80. PubMed ID: 22224483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of hepatic clearance in human from in vitro data for successful drug development.
    Chiba M; Ishii Y; Sugiyama Y
    AAPS J; 2009 Jun; 11(2):262-76. PubMed ID: 19408130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro disposition profiling of heterocyclic compounds.
    Keemink J; Wuyts B; Nicolaï J; Jonghe SD; Stella A; Herdewijn P; Augustijns P; Annaert P
    Int J Pharm; 2015 Aug; 491(1-2):78-90. PubMed ID: 26043826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.
    Bowman CM; Benet LZ
    Pharm Res; 2019 May; 36(8):113. PubMed ID: 31152241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.
    Tess DA; Ryu S; Di L
    Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.
    Ito K; Houston JB
    Pharm Res; 2004 May; 21(5):785-92. PubMed ID: 15180335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of In Vitro-In Vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs.
    Poulin P; Hop CE; Ho Q; Halladay JS; Haddad S; Kenny JR
    J Pharm Sci; 2012 Nov; 101(11):4308-26. PubMed ID: 22890957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs.
    Kimoto E; Mathialagan S; Tylaska L; Niosi M; Lin J; Carlo AA; Tess DA; Varma MVS
    J Pharmacol Exp Ther; 2018 Nov; 367(2):322-334. PubMed ID: 30135178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.